JUPITER NEUROSCIENCES, INC. (JUNS)
$3.02-$1.16 (-27.75%) TodayExtended Hours
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
https://www.jupiterneurosciences.comSEC filings for JUNS on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 11 | 4,310,376 | |
| Option exercise | 16 | 3,079,163 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
22 Form 4 filings on record, the earliest from Jul 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andrew Jon Cutler - Director | Grant or award | Stock Option (right to buy) | 472,222 | $0.00 | - | |
| Julie B. Kampf - Director | Option exercise | Common Stock | 82,875 | - | - | |
| Julie B. Kampf - Director | Option exercise | Restricted Stock Units | 82,875 | $0.00 | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Common Stock | 164,553 | - | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Common Stock | 96,608 | - | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Restricted Stock Units | 164,554 | $0.00 | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Restricted Stock Award | 96,608 | $0.00 | - | |
 Marshall A. Hayward - Officer | Option exercise | Common Stock | 389,793 | - | - | |
| Marshall A. Hayward - Officer | Option exercise | Common Stock | 399,402 | - | - | |
| Marshall A. Hayward - Officer | Option exercise | Common Stock | 225,000 | - | - | |
| Marshall A. Hayward - Officer | Option exercise | Restricted Stock Units | 389,793 | $0.00 | - | |
| Marshall A. Hayward - Officer | Option exercise | Restricted Stock Award | 399,402 | $0.00 | - | |
| Marshall A. Hayward - Officer | Option exercise | Stock Option (right to buy) | 225,000 | $0.00 | - | |
| Nicholas H. Hemmerly - Director | Option exercise | Common Stock | 95,550 | - | - | |
| Nicholas H. Hemmerly - Director | Option exercise | Restricted Stock Units | 95,550 | $0.00 | - | |
 Holger Weis - Director | Option exercise | Common Stock | 85,800 | - | - | |
| Holger Weis - Director | Option exercise | Restricted Stock Units | 85,800 | $0.00 | - | |
| Tomas Jan Philipson - Director | Grant or award | Stock Option (right to buy) | 536,428 | $0.00 | - | |
 Allison W. Brady - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Saleem Elmasri - Officer | Grant or award | Stock Option | 525,565 | $0.00 | - | |
| Christer Rosen - Officer | Grant or award | Stock Option | 747,783 | $0.00 | - | |
| Nicholas H. Hemmerly - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Julie B. Kampf - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Alison D. Silva - Officer | Grant or award | Stock Option | 1,027,304 | $0.00 | - | |
| Marshall A. Hayward - Officer | Grant or award | Stock Option | 259,231 | $0.00 | - | |
| Holger Weis - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Alexander Gustaf Erik Rosen - Officer | Grant or award | Stock Option | 341,843 | $0.00 | - | |
| Saleem Elmasri - Officer | Option exercise | Common Stock | 66,293 | $0.00 | - | |
| Saleem Elmasri - Officer | Grant or award | Stock Option (right to buy) | 102,128 | - | - | |
| Alison D. Silva - Officer | Grant or award | Stock Option (right to buy) | 255,320 | - | - | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $76.97 | $257 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $77.15 | $257 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $77.55 | $259 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 500 | $75.75 | $505 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 3,100 | $76.50 | $3K | |
| Christer Rosen - Officer | Option exercise | Common Stock | 497,396 | $0.00 | - | |
| Christer Rosen - Officer | Option exercise | Common Stock | 476,070 | $0.00 | - | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 166 | $79.50 | $176 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,000 | $73.50 | $980 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 2,000 | $75.75 | $2K | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,450 | $76.50 | $1K | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 700 | $77.25 | $721 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,500 | $78.00 | $2K | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,000 | $78.75 | $1K | |
| Alison D. Silva - Officer | Option exercise | Common Stock | 110,227 | $0.00 | - | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $75.00 | $250 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 100 | $77.62 | $103 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $78.26 | $261 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $78.75 | $263 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 100 | $76.26 | $102 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $76.50 | $255 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $77.25 | $258 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $77.76 | $259 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 100 | $78.72 | $105 |
JUPITER NEUROSCIENCES, INC. (JUNS) had 16 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for JUNS runs to 22 Form 4 filings, the earliest from 2025-07-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of JUNS were filed in the last 90 days. 21 purchases are on record for this company.
No insider sales of JUNS were filed in the last 90 days.
This page tracks JUNS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add JUNS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$KALAKALA BIO, Inc.
$KALVKalVista Pharmaceuticals, Inc.
$KANTKINETA, INC./DE
$KIDSORTHOPEDIATRICS CORP
$KLCKinderCare Learning Companies, Inc.
$KLRSKalaris Therapeutics, Inc.
$KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
$KNSAKiniksa Pharmaceuticals International, plc
$KODKodiak Sciences Inc.
$KPRXKIORA PHARMACEUTICALS INCEvery Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
